Ignite Creation Date:
2024-05-06 @ 7:17 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02503436
Status:
COMPLETED
Last Update Posted:
2023-12-04
First Post:
2015-07-08
Brief Title:
C-PATROL - Non-interventional Study NIS to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm PSR Ovarian Cancer Population
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
C-PATROL - a Single Arm Prospective Non-interventional Study NIS to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm PSR Ovarian Cancer Population
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
C-PATROL
Brief Summary:
The main objective of the proposed non-interventional study is to obtain real-world effectiveness safety and treatment patterns data of patients with BRCAm Breast Cancer Genes mutation positive platinum sensitive relapsed PSR ovarian cancer in German hospitals and outpatient practices treated with olaparib
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None